期刊文献+

RASSF1基因SNP与陕西地区结直肠癌发病风险关系的研究 被引量:1

Correlation between single nucleotide polymorphism of RASSF1 gene and the risk of colorectal carcinoma(CRC)in Shaanxi China
下载PDF
导出
摘要 目的:探讨RASSF1基因第三外显子G133T和第六外显子A315G单核苷酸多态性(SNP)与陕西地区汉族人群结直肠癌(CRC)易感性的关系。方法:采用基于人群的病例对照研究,聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法检测61例CRC和122例健康对照个体RASSF1基因多态位点的基因型频率分布,比较不同基因型与CRC发生风险的关系。结果:RASSF1基因G133T多态的T等位基因频率在CRC患者组为24.6%,显著高于健康对照组的6.1%(P=0.00)。与G/G基因型相比,携带G/T基因型的个体CRC的发病风险显著增加,经性别、年龄、吸烟状况、GIC家族史校正后的OR值为2.33(95%CI=1.05-5.15)。RASSF1基因A315G多态的G等位基因频率在CRC患者组为25.4%,显著高于健康对照组的11.9%(P=0.00)。根据个体吸烟状况进行分层分析发现,与A/A基因型相比,携带A/G基因型和G等位基因(A/G+G/G基因型)可显著增加吸烟个体CRC的发病风险,经性别、年龄、GIC家族史校正后的OR值为4.5(95%CI=1.65-12.28)。根据GIC家族史进行分层分析发现,与A/A基因型相比,携带A/G基因型或G等位基因(A/G+G/G基因型)可显著增加GIC家族史阳性个体CRC的发病风险,经性别、年龄、吸烟状况校正后的OR值为3.78(95%CI=1.39-10.19)。结论:携带RASSF1基因G133T多态的T等位基因(G/T+T/T基因型)可能显著增加陕西地区人群CRC的发病风险。携带RASSF1基因A315G多态的G等位基因(A/G+G/G基因型)可能显著增加陕西地区人群CRC的发病风险。分层分析发现,G等位基因(A/G+G/G基因型)可能显著增加吸烟个体和GIC家族史阳性个体CRC的发病风险。 Objective:To investigate the correlation between single nucleotide polymorphisms(SNPs),G133T and A315G of RASSF1 gene and susceptibilities of CRC in shaanxi Han population.Methods:This population-based case-control study included 61 CRC and 122 healthy controls.Polymorphisms of RASSF1 gene was analyzed by PCR-restriction fragment length polymorphism analysis(RFLP).Results:Frequencies of the RASSF1 G133T T allele in CRC patients was 24.6%,which was significantly higher than that in healthy controls(6.1%)(P=0.00).Compared with individuals with the G/G genotype,individuals with the G/T genotype had significantly higher risk to develop CRC(age,gender,smoking status and family history of GIC adjusted OR=2.33,95%CI=1.05-5.15).Frequencies of the RASSF1 A315G G allele in CRC patients was 25.4%,which was significantly higher than that in healthy controls(11.9%)(P=0.00).When stratified by smoking status,compared with individuals with the A/A genotype,individuals with A/G genotype or G allele(A/G+G/G genotype)had significantly higher risk in developing CRC(age,gender,family history of GIC adjusted OR=4.5 95%CI=1.65-12.28).When stratified by family history of GIC,compared with individuals with A/G genotype or G allele(A/G+G/G genotype)in the group with family history of GIC had significantly higher risk in developing CRC(age,gender,smoking status adjusted OR=3.78 95%CI=1.39-10.19).Conclusion:T allele(G/T+T/T genotype)of RASSF1 G133T SNP significantly increased the risk to developing CRC.G allele(A/G+G/G genotype)of RASSF1 A315G SNP significantly increased the risk of developing CRC.After stratified,individuals with G allele(A/G+G/G genotype)in the group with smoke and with family history of GIC had higher risk in developing CRC.
出处 《现代肿瘤医学》 CAS 2013年第7期1545-1549,共5页 Journal of Modern Oncology
基金 陕西省攻关项目(编号:2003K10-G38)
关键词 结直肠癌 RASSF1基因 单核苷酸多态性 肿瘤易感性 colorectal carcinoma(CRC) RAS association domain family 1(RASSF1)gene single nucleotide polymorphism(SNP) tumor susceptibility
  • 相关文献

参考文献13

  • 1Hirotaka Kanzaki, Hiroko Hanafusa. Single nucleotide polymor- phism at codon 133 of the RASSF1 gene is preferentially associat- ed with human lung adenocarcinoma risk [ J]. Cancer Lett,2006, 238(3) :128 - 134.
  • 2Annika Auranen, Honglin Song, Christy Waterfall, et al. Polymor- phism in DNA repair genes and epithelial ovarian cancer risk[ J]. Int Cancer,2005,117(4) :611 -618.
  • 3Wilmink ABM. Overview of the epidemiology of colorectal cancer [ J]. Dis Colon Rectum, 1997,40 (4) :483.
  • 4Planck M,Anderson H, Bladstron A,et al. Increased cancer risk in offspring of women with colorectal carcinoma: a Swidish register - based cohort study [ J ]. Cancer,2000,89 (4) :741 - 749.
  • 5Yimin Wang, Wei Guo, Yutong He, et al. Association of MTHFR C677T and SHMT1 C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China [ J ]. Cancer Causes Control .2007.18 : 143 - 152.
  • 6Ku Fernandes MS, Carneiro F, Oliveira C, et al. Colorectal cancer and RASSF familyA special emphasis on RASSFIA [ J]. Int J Cancer,2013,132(2) :251 -258.
  • 7vander WL, Papaspyropoulos Angelos, Poulogiannis G, et al. Loss of Rassfl a synergizes with deregulated Runx2 signaling in tumorigene- sis[ J]. Cancer Res ,2012,72( 15 ) :3817 -3827.
  • 8Kim Jin C, Lee Han C, Cho Dong H, et al. Genome - wide identifi- cation of possible methylation markers chemosensitive to targeted regimens in colorectal cancers[ J]. J Cancer Res Clin Oncol,2011, 137(10) :1571 -1580.
  • 9Spitzner M,Emons G,Kramer F, et al. A gene expression signature for chemoradiosensitivity of colorectal cancer cells [ J ]. Int J Radiat Oncol Biol Phys, 2010,78 ( 4 ) : 1184 - 1192.
  • 10付静,张雁军,鲁庆阳,等.结肠癌组织RASSF1A基因转录表达和启动子区甲基化研究[J].现代医学生物进展,2010,10(223):4513-4516.

二级参考文献21

  • 1Dammann R,Li C,Yoon JH,et al.Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J].Nat Genet,2000:25(3):315-319.
  • 2Lerman MI,Minna JD.The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3:identification and evaluation of the resident candidate tumor suppre-ssor genes.The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium[J].Cancer Ras,2000,60(21):6116-6133.
  • 3Byun DS.Lee MG,Chae KS,et al.Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma[J].Cancer Res,2001,61(19):7034-7038.
  • 4Kang GH,Lee S,Kim JS,et al.Profile of aberrant CpG island methylation along multistep gastric carcinogenesis[J].Lab Invest,2003;83(4):519-526.
  • 5Khokhlatchev A,Rabizadeh S.Xavier R,et al.Identification of a novel Ras-regulated proapoptotic pathway[J].Curr Bio,2002,12(4):253-265.
  • 6Pallaés J,Velasco A,Eritja N,et al.Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma[J].Mod Pathol,2008,21(6);691-699.
  • 7Whang YM,Kim YH,Kim JS et al.RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression[J].Cancer Res,2005 Mayl;65(9):3682-3690.
  • 8Yoo YA,Na AR,Lee MS.et al.RASSF1A supprasses oneogenic H-Ras-induced c-Jun N-tenninal kinase activation[J].Int J Oneol,2006,29(6):1541-1547.
  • 9Thaier S,Hhnel PS,Schad A,et al.RASSF1A mediates p21Cip1/Wafldependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and mhibition of Akt[J].Cancer Res,2009,69(5):1748-1757.
  • 10Creasy CL,Ambrose DM,Chernoff J.The Ste20-like protein kinase,Mstl,dimerizes and contains an inhibitory domain[J].J Biol Chem,1996,271:21049-53.

共引文献1

同被引文献19

  • 1Weitz J,Koch M,Debus J,et al.Colorectal cancer[J].Lancet,2005,365(9454):1066-1066.
  • 2Yang Y,Gu X,Zhou M,et al.Serum micro RNAs:A new diagnostic method for colorectal cancer[J].Biomedical Reports,2013,1(4):495-498.
  • 3Ryunosuke K,Koshi M,Fumiaki T,et al.Clinical significance of mi R-146a in gastric cancer cases[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2011,17(13):4277-4284.
  • 4Bond G L,Hu W,Bond E E,et al.A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans[J].Cell,2004,119(5):591-602.
  • 5Gellad Z F,Provenzale D.Colorectal cancer:national and international perspective on the burden of disease and public health impact[J].Revista Brasileira De Farmacognosia,2010,138(6):2177-2190.
  • 6张润虎,张树春,白涛.包头地区结直肠癌发病风险因素的病例对照研究[J].世界最新医学信息文摘(连续型电子期刊),2014,13(36):11-12.
  • 7Anastasia K,Angela R,Jayasena S D.Functional si RNAs and mi RNAs exhibit strand bias[J].Cell,2003,115(2):209-216.
  • 8Ryan B M,Robles A I,Harris C C.Genetic variation in micro RNA networks:the implications for cancer research[J].Nature Reviews Cancer,2010,10(6):389-402.
  • 9Sloane M A,Wong J W H,Dilmi P,et al.Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia[J].Epigenetics Official Journal of the Dna Methylation Society,2014,9(8):1092-1100.
  • 10Azimzadeh P,Romani S,Mirtalebi H,et al.Association of costimulatory human B-lymphocyte antigen B7-2(CD86)gene polymorphism with colorectal cancer risk[J].Gastroenterology&Hepatology from Bed to Bench,2013,6(2):86-91.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部